Publications
342 results found
CROOK D, GODSLAND IF, WYNN V, 1992, CHOLESTEROL, APOLIPOPROTEINS, AND THE RISK OF MYOCARDIAL-INFARCTION, NEW ENGLAND JOURNAL OF MEDICINE, Vol: 326, Pages: 490-491, ISSN: 0028-4793
- Author Web Link
- Cite
- Citations: 1
Crook D, Godsland IF, Wynn V, 1992, Cholesterol, apolipoproteins, and the risk of myocardial infarction., N Engl J Med, Vol: 326, Pages: 490-491, ISSN: 0028-4793
BRUCE R, GODSLAND I, STEVENSON J, et al., 1992, DANAZOL INDUCES RESISTANCE TO BOTH INSULIN AND GLUCAGON IN YOUNG-WOMEN, CLINICAL SCIENCE, Vol: 82, Pages: 211-217, ISSN: 0143-5221
- Author Web Link
- Cite
- Citations: 14
GODSLAND IF, WALTON C, FELTON C, et al., 1992, INSULIN RESISTANCE, SECRETION, AND METABOLISM IN USERS OF ORAL-CONTRACEPTIVES, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, Vol: 74, Pages: 64-70, ISSN: 0021-972X
- Author Web Link
- Cite
- Citations: 184
GODSLAND IF, OLIVER MF, 1991, SYNDROME(S)-X, LANCET, Vol: 337, Pages: 916-916, ISSN: 0140-6736
- Author Web Link
- Cite
- Citations: 1
CROOK D, MONTGOMERY JC, GODSLAND IF, et al., 1991, LIPID AND CARBOHYDRATE-METABOLISM IN PREMENOPAUSAL WOMEN GIVEN SUBDERMAL ESTRADIOL IMPLANTS, HORMONE AND METABOLIC RESEARCH, Vol: 23, Pages: 174-177, ISSN: 0018-5043
- Author Web Link
- Cite
- Citations: 5
GODSLAND IF, CROOK D, WYNN V, 1991, CORONARY HEART-DISEASE RISK MARKERS IN USERS OF LOW-DOSE ORAL-CONTRACEPTIVES, JOURNAL OF REPRODUCTIVE MEDICINE, Vol: 36, Pages: 226-237, ISSN: 0024-7758
- Author Web Link
- Cite
- Citations: 18
Crook D, Godsland IF, Wynn V, 1991, Oral contraceptives and metabolic risk markers for coronary heart disease., Int J Fertil, Vol: 36 Suppl 1, Pages: 38-46, ISSN: 0020-725X
Disturbances in both the plasma lipid profile and in insulin handling have been implicated in the development of coronary heart disease (CHD). Estrogens and progestins are known to affect significantly both lipid and insulin metabolism. Since an increased incidence of myocardial infarction has been identified among users of oral contraceptives (OCs), the metabolic effect of these drugs on risk factors for CHD is of interest. Comparison of a range of monophasic and triphasic OCs that differ primarily in their progestin content has shown that lowering the progestin dose and using a less androgenic steroid reduce the impact on both low-density lipoproteins and high-density lipoproteins (HDLs). In terms of the HDL-2 subfraction, a lipoprotein class that may be of special relevance to the development of CHD, low-dose norethindrone and desogestrel monophasic agents had the least adverse effect. Triglyceride levels were increased by the low-dose OCs used in this study; this may be an unavoidable consequence of current trends in OC development. However, the clinical significance of these increased triglyceride levels is not clear. Glucose tolerance deteriorated similarly with all the formulations in this study, although the effect on insulin concentrations was less marked with formulations containing lower doses of progestins. It was concluded that reducing the progestin dose and changing the progestin type effectively reduce the adverse impact of OCs on metabolic risk for CHD. Although further study is recommended, the use of OC formulations without adverse effects on risk profile is indicated.
GODSLAND IF, CROOK D, SIMPSON R, et al., 1990, THE EFFECTS OF DIFFERENT FORMULATIONS OF ORAL-CONTRACEPTIVE AGENTS ON LIPID AND CARBOHYDRATE-METABOLISM, NEW ENGLAND JOURNAL OF MEDICINE, Vol: 323, Pages: 1375-1381, ISSN: 0028-4793
- Author Web Link
- Cite
- Citations: 354
STEVENSON JC, GODSLAND IF, BRUCE R, et al., 1990, OBESITY AND RISK OF CORONARY HEART-DISEASE IN WOMEN, NEW ENGLAND JOURNAL OF MEDICINE, Vol: 323, Pages: 1143-1144, ISSN: 0028-4793
- Author Web Link
- Cite
- Citations: 1
WYNN V, GODSLAND I, WALTON C, 1990, CAN LIFE-STYLE CHANGES REVERSE CORONARY HEART-DISEASE, LANCET, Vol: 336, Pages: 624-625, ISSN: 0140-6736
- Author Web Link
- Cite
- Citations: 4
GODSLAND IF, CROOK D, WYNN V, 1990, LOW-DOSE ORAL-CONTRACEPTIVES AND CARBOHYDRATE-METABOLISM, AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, Vol: 163, Pages: 348-353, ISSN: 0002-9378
- Author Web Link
- Cite
- Citations: 23
WYNN V, GODSLAND IF, STEVENSON JC, 1990, MORTALITY AMONG ORAL-CONTRACEPTIVE USERS, BRITISH MEDICAL JOURNAL, Vol: 300, Pages: 331-331, ISSN: 0959-8138
MONTGOMERY JC, CROOK D, GODSLAND IF, et al., 1989, PLASMA-LIPID RISK-FACTORS IN OOPHORECTOMIZED WOMEN, BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol: 96, Pages: 1236-1238, ISSN: 0306-5456
- Author Web Link
- Cite
- Citations: 11
CROOK D, GODSLAND IF, WYNN V, 1989, HDL AS AN INDEPENDENT RISK FACTOR IN BRITISH MEN (AND WOMEN), BMJ-BRITISH MEDICAL JOURNAL, Vol: 298, Pages: 1249-1249, ISSN: 1756-1833
Crook D, Godsland IF, Wynn V, 1989, HDL as an independent risk factor in British men (and women)., BMJ, Vol: 298, ISSN: 0959-8138
Crook D, Godsland IF, Wynn V, 1989, Lack of metabolic effects of a triphasic formulation containing norethindrone in normal women studied prospectively., Contraception, Vol: 39, Pages: 125-128, ISSN: 0010-7824
WYNN V, GODSLAND I, SIMPSON R, et al., 1989, CARBOHYDRATE AND LIPID-METABOLISM IN LOW-DOSE ORAL CONTRACEPTION, 12TH WORLD CONGRESS OF GYNECOLOGY AND OBSTETRICS, Publisher: PARTHENON PUBLISHING GROUP LTD, Pages: 287-298
GODSLAND IF, WYNN V, CROOK D, 1988, MENOPAUSE AND CORONARY-DISEASE - REPLY, AMERICAN HEART JOURNAL, Vol: 116, Pages: 1649-1649, ISSN: 0002-8703
- Author Web Link
- Cite
- Citations: 3
CROOK D, GODSLAND IF, WYNN V, 1988, ORAL-CONTRACEPTIVES AND CORONARY HEART-DISEASE - MODULATION OF GLUCOSE-TOLERANCE AND PLASMA-LIPID RISK-FACTORS BY PROGESTINS, AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, Vol: 158, Pages: 1612-1620, ISSN: 0002-9378
- Author Web Link
- Cite
- Citations: 49
GODSLAND IF, WYNN V, CROOK D, et al., 1987, SEX, PLASMA-LIPOPROTEINS, AND ATHEROSCLEROSIS - PREVAILING ASSUMPTIONS AND OUTSTANDING QUESTIONS, AMERICAN HEART JOURNAL, Vol: 114, Pages: 1467-1503, ISSN: 0002-8703
- Author Web Link
- Cite
- Citations: 299
GODSLAND IF, WYNN V, 1987, DERIVATION OF A QUANTITATIVE MEASURE OF INSULIN SENSITIVITY FROM THE INTRAVENOUS TOLBUTAMIDE TEST USING THE MINIMAL MODEL OF GLUCOSE DYNAMICS - RESPONSE, DIABETOLOGIA, Vol: 30, Pages: 756-756, ISSN: 0012-186X
PARR JH, SEED M, GODSLAND I, et al., 1987, THE EFFECTS OF REVERSE SEQUENTIAL ANTIANDROGEN THERAPY (CYPROTERONE-ACETATE AND ETHINYL ESTRADIOL) ON HEMATOLOGICAL PARAMETERS, JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, Vol: 10, Pages: 237-239, ISSN: 0391-4097
- Author Web Link
- Cite
- Citations: 6
SHENNAN NM, GODSLAND IF, WYNN V, 1987, DERIVATION OF A QUANTITATIVE MEASURE OF INSULIN SENSITIVITY FROM THE INTRAVENOUS TOLBUTAMIDE TEST USING THE MINIMAL MODEL OF GLUCOSE DYNAMICS, DIABETOLOGIA, Vol: 30, Pages: 314-322, ISSN: 0012-186X
- Author Web Link
- Cite
- Citations: 7
GODSLAND IF, SHENNAN NM, WYNN V, 1986, INSULIN ACTION AND DYNAMICS MODELED IN PATIENTS TAKING THE ANABOLIC-STEROID METHANDIENONE (DIANABOL), CLINICAL SCIENCE, Vol: 71, Pages: 665-673, ISSN: 0143-5221
- Author Web Link
- Cite
- Citations: 32
Wynn V, Godsland I, 1986, Effects of oral contraceptives on carbohydrate metabolism., J Reprod Med, Vol: 31, Pages: 892-897, ISSN: 0024-7758
Both estrogens and progestogens modify carbohydrate metabolism, and their ultimate effect depends upon the ratio of one to the other. The effect of progestogens themselves, which are responsible for increased insulin secretion and for insulin resistance, varies according to their androgenicity but increases according to the series pregnane, estrane and gonane. In contrast, estrogens impair the initial secretion of insulin by the pancreas. The prolonged use of combined oral contraceptives containing the powerful progestogen levonorgestrel is associated with mild but continuing glucose intolerance and with marked insulin resistance.
WYNN V, GODSLAND I, 1986, EFFECTS OF ORAL-CONTRACEPTIVES ON CARBOHYDRATE-METABOLISM, JOURNAL OF REPRODUCTIVE MEDICINE, Vol: 31, Pages: 892-897, ISSN: 0024-7758
- Author Web Link
- Cite
- Citations: 32
WYNN V, CROOK D, GODSLAND IF, et al., 1986, HIGH-DENSITY-LIPOPROTEIN IS NOT A MAJOR RISK FACTOR FOR ISCHEMIC-HEART-DISEASE IN BRITISH MEN - REPLY, BRITISH MEDICAL JOURNAL, Vol: 292, Pages: 1200-1200, ISSN: 0959-8138
- Author Web Link
- Cite
- Citations: 1
WYNN V, CROOK D, GODSLAND IF, et al., 1986, HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IS NOT A MAJOR RISK FACTOR FOR ISCHEMIC-HEART-DISEASE IN BRITISH MEN, BMJ-BRITISH MEDICAL JOURNAL, Vol: 292, Pages: 1013-1013, ISSN: 1756-1833
- Author Web Link
- Cite
- Citations: 3
WYNN V, GODSLAND IF, SEED M, et al., 1986, PARADOXICAL EFFECTS OF THE ANTIANDROGEN CYPROTERONE-ACETATE ON LIPID AND LIPOPROTEIN METABOLISM, CLINICAL ENDOCRINOLOGY, Vol: 24, Pages: 183-191, ISSN: 0300-0664
- Author Web Link
- Cite
- Citations: 20
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.